ADIPOQ and viral hepatitis: In addition, increasing reports have shown that liver function impairment and steatosis are strongly correlated with adiponectin in the patients with viral hepatitis (e.g., hepatitis C virus) [51, 52] and non-alcoholic steatohepatitis [53].